Ibáñez, L.; Nácher-Juan, J.; Terencio, M.C.; Ferrándiz, M.L.; Alcaraz, M.J.
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1. Int. J. Mol. Sci. 2022, 23, 8551.
https://doi.org/10.3390/ijms23158551
AMA Style
Ibáñez L, Nácher-Juan J, Terencio MC, Ferrándiz ML, Alcaraz MJ.
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1. International Journal of Molecular Sciences. 2022; 23(15):8551.
https://doi.org/10.3390/ijms23158551
Chicago/Turabian Style
Ibáñez, Lidia, Josep Nácher-Juan, MarÃa Carmen Terencio, MarÃa Luisa Ferrándiz, and MarÃa José Alcaraz.
2022. "Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1" International Journal of Molecular Sciences 23, no. 15: 8551.
https://doi.org/10.3390/ijms23158551
APA Style
Ibáñez, L., Nácher-Juan, J., Terencio, M. C., Ferrándiz, M. L., & Alcaraz, M. J.
(2022). Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1. International Journal of Molecular Sciences, 23(15), 8551.
https://doi.org/10.3390/ijms23158551